March 2018 – NovAccess Global

Innovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences Company

Innovest Global Inc. to Launch Biotech and Health Sciences Division Led by World Renowned Neuroscientist, Dr. Dwain Morris-Irvin

Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Forward-Looking Statements

Contact Us

JOIN US

Stay up-to-date with our journey

Forward-Looking Statements